ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 140 filers reported holding ARCELLX INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $4,257,156 | +33.7% | 61,210 | +6.7% | 0.00% | +100.0% |
| Q4 2023 | $3,184,257 | +44.6% | 57,374 | -6.5% | 0.00% | 0.0% |
| Q3 2023 | $2,201,776 | -71.2% | 61,365 | -74.7% | 0.00% | -75.0% |
| Q2 2023 | $7,656,309 | +205604.2% | 242,135 | +100.4% | 0.00% | +100.0% |
| Q1 2023 | $3,722 | +71.0% | 120,798 | +71.9% | 0.00% | +100.0% |
| Q4 2022 | $2,177 | -99.5% | 70,277 | +230.9% | 0.00% | – |
| Q3 2022 | $399,000 | -74.2% | 21,238 | -75.2% | 0.00% | -100.0% |
| Q2 2022 | $1,546,000 | +20.9% | 85,501 | -6.3% | 0.00% | 0.0% |
| Q1 2022 | $1,279,000 | – | 91,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 2,346,630 | $129,510,510 | 40.55% |
| NEA Management Company, LLC | 3,745,262 | $206,701,010 | 15.55% |
| Paradigm Biocapital Advisors LP | 3,848,095 | $212,376,363 | 8.13% |
| Samsara BioCapital, LLC | 453,641 | $25,036,447 | 5.24% |
| GREAT POINT PARTNERS LLC | 492,000 | $27,153,480 | 5.20% |
| Perceptive Advisors | 3,889,739 | $214,674,695 | 5.17% |
| Cormorant Asset Management, LP | 1,525,000 | $84,164,750 | 4.86% |
| STEMPOINT CAPITAL LP | 280,709 | $15,492,330 | 4.55% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 59,133 | $3,263,550 | 4.11% |
| Cutter Capital Management, LP | 187,000 | $10,320,530 | 3.12% |